The Drug Enforcement Administration is pleased to provide you with the 2022 edition of the Pharmacist’s Manual to assist you in understanding the provisions of the Controlled Substances Act (CSA) and its implementing regulations.
Manuals - DEA Diversion Control Division
NOTE: The DEA Diversion Control Division is currently updating all of the manuals.
1 This manual replaces all previous editions of the Practitioner’s Manual issued by the Drug Enforcement Administration, both hard copy and electronic.
The Drug Enforcement Administration is pleased to provide this updated edition of the 1990 Practitioner’s Manual to assist you in understanding your responsibilities under the Controlled Substances Act (CSA) and its implementing regulations.
A. Terminology used in the Analysis of Drugs Manual (ADM) is defined in Appendix 1A. B. Use of abbreviations is defined in Appendix 1B.
• The drug or other substance has a low potential for abuse relative to the drugs or other substances in Schedule IV. • The drug or other substance has a currently accepted medical use in treatment in the United States. • Abuse of the drug or other substances may lead to limited physical dependence or psychological
Analysis of Drugs Manual - DEA.gov
Jun 15, 2021 · This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is March 29, 2021 to September 28, 2023 and it is provided for informational purposes only.
This manual has been prepared by the Drug Enforcement Administration, Office of Diversion Control, as a guide to assist pharmacists in their understanding of the Federal Controlled Substances Act and its implementing regulations as they pertain to the pharmacy profession.
The Drug Enforcement Administration (DEA) is pleased to provide you with the 2022 edition of the Narcotic Treatment Program Manual (NTP Manual) to assist you in understanding the provisions of the Controlled Substances Act (CSA).
Guidance Documents - United States Department of Justice
This guidance document addresses when a Drug Enforcement Administration (DEA)-registered reverse distributor is considered to have received a sealed inner liner from either DEA registrants authorized as collectors or Federal, State, Tribal, or local law enforcement agencies.
- Some results have been removed